These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35108572)

  • 61. Arthritis of the left elbow joint after vaccination against SARS-CoV-2 infection.
    Baimukhamedov C
    Int J Rheum Dis; 2021 Sep; 24(9):1218-1220. PubMed ID: 34363344
    [No Abstract]   [Full Text] [Related]  

  • 62. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis.
    Spertini F; Leimgruber A; Morel B; Khazaeli MB; Yamamoto K; Dayer JM; Weisbart RH; Lee ML
    J Rheumatol; 1999 Dec; 26(12):2602-8. PubMed ID: 10606369
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus--a 20-year experience in Asia.
    Lee PY; Yeh KW; Yao TC; Lee WI; Lin YJ; Huang JL
    Lupus; 2013 Dec; 22(14):1534-40. PubMed ID: 23966304
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort.
    Cann MP; Sage AM; McKinnon E; Lee SJ; Tunbridge D; Larkins NG; Murray KJ
    Lupus; 2022 Feb; 31(2):246-255. PubMed ID: 35037500
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bacillus Calmette-Guérin scar flare after an mRNA SARS-CoV-2 vaccine.
    Lim DW; Ng DHL; Low JG
    CMAJ; 2021 Aug; 193(30):E1178. PubMed ID: 34344774
    [No Abstract]   [Full Text] [Related]  

  • 67. Lupus nephritis in children.
    Gupta KL
    Indian J Pediatr; 1999; 66(2):215-23. PubMed ID: 10798064
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Obesity increases the incidence of new-onset lupus nephritis and organ damage during follow-up in patients with systemic lupus erythematosus.
    Kang JH; Xu H; Choi SE; Park DJ; Lee JK; Kwok SK; Kim SK; Choe JY; Kim HA; Sung YK; Shin K; Lee SS
    Lupus; 2020 May; 29(6):578-586. PubMed ID: 32208798
    [No Abstract]   [Full Text] [Related]  

  • 69. Lupus Podocytopathy: An Overview.
    Oliva-Damaso N; Payan J; Oliva-Damaso E; Pereda T; Bomback AS
    Adv Chronic Kidney Dis; 2019 Sep; 26(5):369-375. PubMed ID: 31733721
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis.
    van Tellingen A; Voskuyl AE; Vervloet MG; Bijl M; de Sévaux RG; Berger SP; Derksen RH; Berden JH;
    Neth J Med; 2012 May; 70(4):199-207. PubMed ID: 22641632
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively.
    Nossent JC; Bronsveld W; Swaak AJ
    Ann Rheum Dis; 1989 Oct; 48(10):810-6. PubMed ID: 2818017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Coagulopathy as a complication of kidney biopsies in paediatric systemic lupus erythematosus patients with antiphospholipid syndrome.
    Nagata H; Sato M; Ogura M; Yoshikawa T; Yamamoto K; Matsumura S; Kano Y; Saida K; Sako M; Kamei K; Yoshioka T; Ogata K; Ito S; Ishikura K
    Nephrology (Carlton); 2018 Jun; 23(6):592-596. PubMed ID: 28976051
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Considerations for COVID-19 vaccination in pregnancy.
    Zamparini J; Murray L; Saggers RT; Wise AJ; Lombaard H
    S Afr Med J; 2021 Apr; 111(6):544-549. PubMed ID: 34382563
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Letter Regarding "Delayed-onset Anaphylaxis After COVID-19 Vaccination".
    Mungmunpuntipantip R; Wiwanitkit V
    Pediatr Infect Dis J; 2022 Aug; 41(8):e342. PubMed ID: 35476625
    [No Abstract]   [Full Text] [Related]  

  • 75. Renal outcome and predictors of clinical renal involvement in patients with silent lupus nephritis.
    Wada Y; Ito S; Ueno M; Nakano M; Arakawa M; Gejyo F
    Nephron Clin Pract; 2004; 98(4):c105-11. PubMed ID: 15627787
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New-onset autoimmune phenomena post-COVID-19 vaccination.
    Chen Y; Xu Z; Wang P; Li XM; Shuai ZW; Ye DQ; Pan HF
    Immunology; 2022 Apr; 165(4):386-401. PubMed ID: 34957554
    [TBL] [Abstract][Full Text] [Related]  

  • 77. International survey on the management of patients with SLE. III. The results of a questionnaire regarding renal involvement.
    Doria A; Vitali C; Tincani A; Balestrieri G; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 16():S31-8. PubMed ID: 9049451
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Micronutrient supplementation, COVID-19 vaccination and adverse effect: Correspondence.
    Mungmunpuntipantip R; Wiwanitkit V
    Clin Nutr ESPEN; 2022 Apr; 48():479. PubMed ID: 35331532
    [No Abstract]   [Full Text] [Related]  

  • 79. Late-onset biopsy-proven lupus nephritis without other associated autoimmune diseases: severity and long-term outcome.
    Ugolini-Lopes MR; Santos LPS; Stagnaro C; Seguro LPC; Mosca M; Bonfá E
    Lupus; 2019 Jan; 28(1):123-128. PubMed ID: 30442061
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.
    Seelen MA; Trouw LA; Daha MR
    Curr Opin Nephrol Hypertens; 2003 Nov; 12(6):619-24. PubMed ID: 14564199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.